Medical New Infrastructure Stocks Leading Stocks

Medical New Infrastructure Stocks Leading Stocks

Medical New Infrastructure Stocks Leading Stocks, which requires access to relevant information in order to answer the question, according to years of learning experience, if the answer to the question of Medical New Infrastructure Stocks Leading Stocks, it can make you twice as easy as twice as easy, and the following share of Medical New Infrastructure Stocks Leading Stocks related methodology experience for your reference and reference.

Medical New Infrastructure Stocks Leading Stocks

Medical New Infrastructure Stocks Leading Stocks include:

______ Neusoft Group. ____ The company is one of the 55 large-scale medical and health science and technology promotion centers of the Ministry of Health of the People's Republic of China, and has undertaken a major scientific research project under the National 863 Program, "Computer-aided Pharmaceutical Preparation Design System".

______ Weining Health. ____ The company focuses on healthcare informatization, and its main business includes medical informatization system, medical informatization service and overall solution of medical informatization.

______ Baolite. ____ The company is a medical device R&D, manufacturing, sales and service company, with its main products being medical monitoring products.

______ Kehua Bio. ____ The company is a national high-tech enterprise, and its in vitro diagnostic reagent products cover four major categories: immunodiagnostic, biochemical diagnostic, microbial testing, and clinical test reagents.

______ Zhongxin Pharmaceutical. ____ The company is a large Chinese pharmaceutical and health industry group integrating three major industries: pharmaceutical research and development, drug manufacturing and medical services.

______Huaping. ____ The company's main business is the research and development, production, sales and service of informationization and intelligent series of products and solutions with video applications as the core.

______Digital Zhengtong. ____ The company is an e-government solution provider focusing on the field of urban management informatization, mainly serving the departments related to urban management such as housing construction, planning, public security, human defense, civil affairs and municipal affairs.

______ Yinjiang shares. ____ The company is a national key high-tech enterprise with urban intelligent transportation system planning, construction and operation services as its core, as well as engaging in the research, development and manufacturing of intelligent transportation chips and intelligent transportation products.

______ Xinkaipu. ____ The company is a high-tech enterprise specializing in intelligent transportation systems and industry application solutions, with a number of patented technologies such as traffic control, vehicle wireless, bus navigation and mobile payment.

______ Thousand Square Technology. ____ The company is a leading domestic intelligent transportation leader, with the world's leading artificial intelligence, high-precision map positioning, vehicle-circuit coordination and other technology accumulation and R & D strength, business covers intelligent transportation, car networking and other application areas.

The above are some of the leading medical new infrastructure stocks, investment risk, specific investment decisions also need to be made according to individual risk appetite, investment objectives and market conditions. Before making an investment decision, it is recommended that you conduct adequate research and analysis.

Medical new infrastructure what stocks

2023 medical new infrastructure concept stocks are:

1.EVERRISE TECHNOLOGY (688301): EVERRISE TECHNOLOGY medical digital X-ray machine, automatic chemiluminescence immunoassay analyzer, automatic biochemical analyzers, hemocytometer analyzers, blood analysis pipeline, urinalysis Line, blood analyzer, chemiluminescence immunoassay analyzer and other products to obtain the third class of medical equipment products, medical device registration license.

2. Chutian Science and Technology (300358): Chutian Science and Technology has signed a strategic cooperation agreement with the U.S. GE Healthcare, becoming the first domestic enterprises to get the U.S. GEP4 verification certificate, Chutian Science and Technology, Myriad Healthcare, Changchun High-tech, Aide Bio, Weiguang life and other five enterprises were evaluated as a national enterprise technology center.

3. Baoti (600456): the company for the China Aerospace Science and Technology Group Corporation, the only titanium and titanium alloy products specialized manufacturing, scientific research and development, production and service bases, China's largest high-end titanium R & D manufacturer, China's largest high-tech listed companies in Northwest China, Shaanxi Province, the first listed company, the domestic high-end titanium material variety is the most complete, the most advanced technology, the largest production scale, is the state-designated titanium material, the most advanced technology, the most advanced technology, the largest production scale, and the most advanced production scale. The largest, is the national designated titanium and titanium alloy materials production and research base.

The above are just some of the medical new infrastructure concept stocks, you can pay attention to the announcement of these companies to get the latest information.

Medical New Infrastructure Potential Leading Stocks

Medical New Infrastructure Potential Leading Stocks, you can consider the following stocks:

___Bao Laitai: the company is a leading supplier of medical equipment and reagents in the country, and in recent years under the impetus of the new infrastructure of medical care, the performance of the company is expected to be improved.

__Contact Medical: The company specializes in the research, development, production and sales of POCT reagents and instruments, and in recent years, under the influence of the new crown epidemic in China, the market scale of the POCT industry has been expanding, and the performance of the company's medical performance has also improved.

__Myriad Medical: The company is a leading global provider of medical equipment and solutions, and in recent years, under the impetus of the new domestic medical infrastructure, the company's development prospects are promising.

It should be noted that the above are just some of the leading stocks that may have the potential for new medical infrastructure. Investment involves risk, and investors should choose and analyze according to their own risk appetite and investment objectives.

Medical new infrastructure leading stocks are which

Medical new infrastructure leading stocks are:

1. Baoli International: Baoli International based on overseas, deep plowing long trade, and gradually formed a third-party distribution of its Dahl in vitro diagnostic products and consumables for the main business of the international trade company.

2. Weiyuan: Weiyuan In-Vitro Diagnostic Kit is an in-vitro diagnostic reagents and consumables integrating production, sales and research and development, with its products covering the fields of immuno-diagnostics, biochemical diagnostics and blood diagnostics.

3. Medicine Stone Technology: Medicine Stone Technology is a drug molecular masonry and drug intermediates research and development, production and sales of companies.

4. Guangyuyuan: Guangyuyuan Traditional Chinese Medicine Co., Ltd. was founded in the Jiajing period of the Ming Dynasty, and is an ancient and famous Chinese medicine brand. The company's traditional Chinese medicine products include Guilingji, Dingkundan, and Angong Niuhuangwan.

Warm tips: the above content is for reference only, because the stock market is real-time fluctuations, so the above information may have a lag or inaccurate, investment should be cautious.

Medical New Infrastructure Leading Stocks

Medical New Infrastructure Leading Stocks include Neusoft Group, Wei-Ning Health, Baolite, Dasi Intelligence, Aier Ophthalmology, Wanda Information, Dongfang Biologicals, Qidi Guhan, Bishuiyuan, and China Pharmaceuticals.

Please note that the stocks mentioned above do not represent any investment advice and are not investment recommendations. Investors should choose investment targets carefully according to their own risk tolerance and market conditions.

That's it for the introduction of leading medical new infrastructure stocks.